Pimavanserin and emotional processing (PANDER) Study
We are investigating how a single dose of pimavanserin (a medication for Parkinson’s-related psychosis) affects emotional processing. The study will involve a 1-hour call to assess eligibility and a single in-person visit at Warneford Hospital (OX3 7JX) involving: physical checks (ECG, blood pressure, BMI), saliva samples and questionnaires, drug administration, a 4-hour break and computerised tasks.
Ethics Approval Reference: R95550/RE001
We are looking for
Healthy English-speaking participants aged 18-45 with no history of psychiatric (e.g., anxiety, depression) or cardiac disorders.
Expenses
£135 plus reasonable travel expenses